Close

Exactech (EXAC), TPG Capital Amend Merger Agreement Providing for Increase in Consideration to $49.25/Share

December 4, 2017 8:02 AM EST Send to a Friend
Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login